Biliary Interventional Radiology Devices Market Segmentation:
Type Segment Analysis
The biliary stents segment is projected to garner 31.5% market share by 2034, owing to their high usability in managing benign obstructions and malignancies. According to the National Institute of Health, the usage of biliary stenting remarkably enhances the survival rate of unresectable cholangiocarcinoma patients. The adoption in the inpatient and outpatient settings is also increasing due to increased reimbursement support for the drug-eluting as well as metallic stents under the Medicare policies. Also, there is a huge investment in research and development in making biodegradable stents, further fueling the segment's growth.
End User Segment Analysis
The hospital segment is anticipated to gather a 45.2% share by 2034. The segment growth can be attributed to the accessibility of hospitals to state-of-the-art IR suites. According to the Agency for Healthcare Research and Quality, various hospitals have included quality improvement initiatives, such as image-guided biliary intervention, as a standard for high-risk cases. The procurement of the device is made possible via public tenders to ensure long-lasting growth and cost efficiency. Hospitals are hiring specialized interventional radiologists to give adequate treatment to the patients.
Our in-depth analysis of the global biliary interventional radiology devices market includes the following segments:
|
Segment |
Subsegments |
|
Type |
|
|
Procedure |
|
|
Material |
|
|
Applications |
|
|
End user |
|
|
Technology |
|
